Mediterranean diet improves blastocyst formation in women previously infected COVID-19: a prospective cohort study.

IVF outcomes embryo mediterranean diet post COVID-19 pregnancy

Journal

Frontiers in nutrition
ISSN: 2296-861X
Titre abrégé: Front Nutr
Pays: Switzerland
ID NLM: 101642264

Informations de publication

Date de publication:
2024
Historique:
received: 17 01 2024
accepted: 13 06 2024
medline: 5 7 2024
pubmed: 5 7 2024
entrez: 5 7 2024
Statut: epublish

Résumé

Our study tries to investigate the effect of the Mediterranean diet (MeDiet) on assisted reproductive treatment outcomes in women after COVID-19 infection. A prospective observational cohort study in the Reproductive and Genetic Hospital of CITIC-Xiangya from February 2023 to August 2023.Subjects: A total of 605 participants previously infected with COVID-19 were enrolled. None. The primary outcomes are oocyte and embryo quality. The secondary outcomes are pregnancy outcomes. A majority of participants ( High adherence to MeDiet is associated with improved blastocyst formation in women after COVID-19 infection. There is also a trend that high adherence to MeDiet might be beneficial to clinical pregnancy, embryo implantation as well as ongoing pregnancy in these women.

Identifiants

DOI: 10.3389/fnut.2024.1371077 PMID: 38966424 PMC: PMC11222606
pubmed: 38966424
doi: 10.3389/fnut.2024.1371077
pmc: PMC11222606
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1371077

Informations de copyright

Copyright © 2024 Chen, Wang, Guo, Zhao, Lin, Hocher, Kalk, Wang and Gong.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Huijun Chen (H)

Clinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha, Hunan, China.
Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.
Department of Nephrology, Charité Universitätsmedizin Berlin, Berlin, Germany.

Jing Wang (J)

Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.

Hongxin Guo (H)

Clinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha, Hunan, China.
Institute of Reproductive and Stem Cell Engineering, NHC Key Laboratory of Human Stem Cell and Reproductive Engineering, School of Basic Medical Science, Central South University, Changsha, Hunan, China.

Qi Zhao (Q)

Clinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha, Hunan, China.
Institute of Reproductive and Stem Cell Engineering, NHC Key Laboratory of Human Stem Cell and Reproductive Engineering, School of Basic Medical Science, Central South University, Changsha, Hunan, China.

Ge Lin (G)

Clinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha, Hunan, China.
Institute of Reproductive and Stem Cell Engineering, NHC Key Laboratory of Human Stem Cell and Reproductive Engineering, School of Basic Medical Science, Central South University, Changsha, Hunan, China.
Key Laboratory of Stem Cells and Reproductive Engineering, Ministry of Health, Changsha, China.

Berthold Hocher (B)

Clinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha, Hunan, China.
Key Laboratory of Stem Cells and Reproductive Engineering, Ministry of Health, Changsha, China.
Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology/Pneumology), University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany.
Institute of Medical Diagnostics, IMD, Berlin, Germany.

Philipp Kalk (P)

Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.
Diaverum Renal Care Center, Diaverum MVZ Am Neuen Garten Standort Ludwigsfelde, Potsdam, Germany.

Zetao Wang (Z)

Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology/Pneumology), University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany.
Department of Gastroenterology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.

Fei Gong (F)

Clinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha, Hunan, China.
Institute of Reproductive and Stem Cell Engineering, NHC Key Laboratory of Human Stem Cell and Reproductive Engineering, School of Basic Medical Science, Central South University, Changsha, Hunan, China.
Key Laboratory of Stem Cells and Reproductive Engineering, Ministry of Health, Changsha, China.

Classifications MeSH